Boris C. Bastian

Q: What Schools Are Affiliated With Boris C. Bastian

Boris C. Bastian is affiliated with the following schools: University of California, Berkeley, Stanford University, University of Florence, University of California, San Francisco, New York University

Boris C. Bastian's AcademicInfluence.com Rankings

Boris C. Bastian

Computer Science

#7724

World Rank

#8129

Historical Rank

Computational Linguistics

#1600

World Rank

#1617

Historical Rank

Machine Learning

#2954

World Rank

#2991

Historical Rank

Artificial Intelligence

#3248

World Rank

#3296

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Boris C. Bastian's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Boris C. Bastian Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Boris C. Bastian's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genomic Classification of Cutaneous Melanoma (2015) (2143)
Distinct sets of genetic alterations in melanoma. (2005) (2032)
Somatic activation of KIT in distinct subtypes of melanoma. (2006) (1473)
Mutations in GNA11 in uveal melanoma. (2010) (1036)
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing (2016) (1012)
The Genetic Evolution of Melanoma from Precursor Lesions. (2015) (748)
Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi (2008) (676)
Determinants of BRAF mutations in primary melanomas. (2003) (649)
KIT as a therapeutic target in metastatic melanoma. (2011) (648)
Germline mutations in BAP1 predispose to melanocytic tumors (2011) (635)
From melanocytes to melanomas (2016) (543)
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. (2013) (528)
Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. (1998) (527)
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas (2014) (465)
The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer (2007) (458)
Classifying melanocytic tumors based on DNA copy number changes. (2003) (445)
Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. (2000) (407)
The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. (2014) (381)
Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. (2014) (366)
Improving Melanoma Classification by Integrating Genetic and Morphologic Features (2008) (354)
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway (2006) (348)
Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. (1999) (314)
Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. (2007) (312)
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. (2007) (307)
Cyclin D1 is a candidate oncogene in cutaneous melanoma. (2002) (281)
Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. (2000) (262)
The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin (2011) (252)
Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma (2009) (248)
A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression (2012) (241)
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. (2006) (232)
Dose‐dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation (2008) (219)
Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. (2002) (207)
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway (2015) (204)
Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism (2017) (199)
MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma (2006) (197)
BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site (2011) (194)
Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool (2006) (184)
Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations (2014) (179)
Sunitinib Therapy for Melanoma Patients with KIT Mutations (2012) (177)
Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas (2001) (175)
The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. (2020) (166)
Pervasive chromosomal instability and karyotype order in tumour evolution (2020) (160)
MC1R germline variants confer risk for BRAF-mutant melanoma. (2006) (158)
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets (2019) (155)
Frequent mutations in the MITF pathway in melanoma (2009) (154)
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy (2016) (153)
A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. (2002) (152)
Genetic and morphologic features for melanoma classification (2010) (144)
Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination (2015) (133)
Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer (2003) (126)
Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution. (2018) (126)
The genetic evolution of metastatic uveal melanoma (2019) (125)
Activating MET Kinase Rearrangements in Melanoma and Spitz Tumors (2015) (124)
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma (2009) (123)
Mutations in GNA 11 in Uveal Melanoma (119)
HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma. (2001) (118)
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma (2013) (118)
Interleukin‐10 production in malignant melanoma: Preferential detection of IL‐10‐secreting tumor cells in metastatic lesions (1996) (115)
KIT as a therapeutic target in melanoma. (2010) (115)
Mutation-driven drug development in melanoma (2010) (113)
Clinical, Histopathologic, and Genomic Features of Spitz Tumors With ALK Fusions (2015) (111)
NTRK3 kinase fusions in Spitz tumours (2016) (111)
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma (2009) (108)
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial (2017) (107)
Persistent (Recurrent) Spitz Nevi: A Histopathologic, Immunohistochemical, and Molecular Pathologic Study of 22 Cases (2002) (107)
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy (2013) (105)
The genetic landscape of ganglioglioma (2018) (105)
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition (2015) (101)
Frequent p16-independent inactivation of p14ARF in human melanoma. (2008) (101)
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. (2017) (100)
Genetic and molecular characterization of uveal melanoma cell lines (2012) (99)
Melanoma in childhood: An EORTC‐MCG multicenter study on the clinico‐pathological aspects (1996) (97)
Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients (1993) (95)
Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi (2017) (91)
Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. (2004) (91)
MC1R variants increase risk of melanomas harboring BRAF mutations. (2008) (90)
Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma (2010) (90)
Targeted genomic profiling of acral melanoma. (2019) (89)
Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation. (2018) (89)
Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma (2018) (87)
Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. (2013) (87)
Chromosomal aberrations in angioimmunoblastic T‐cell lymphoma and peripheral T‐cell lymphoma unspecified: A matrix‐based CGH approach (2007) (84)
Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma (2019) (83)
Genomic Analysis of Blue Nevi and Related Dermal Melanocytic Proliferations (2005) (83)
Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. (2008) (81)
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. (2002) (81)
Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice (2002) (80)
Genomic Profiling of Malignant Peritoneal Mesothelioma Reveals Recurrent Alterations in Epigenetic Regulatory Genes BAP1, SETD2, and DDX3X (2016) (80)
Preoperative characterization of pigmented skin lesions by epiluminescence microscopy and high-frequency ultrasound. (1995) (79)
Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis (2010) (79)
The state of melanoma: challenges and opportunities (2016) (79)
Biology of advanced uveal melanoma and next steps for clinical therapeutics (2014) (79)
Ambiguous Melanocytic Tumors With Loss of 3p21 (2014) (73)
The genetic landscape of anaplastic pleomorphic xanthoastrocytoma (2018) (72)
PI3-kinase subunits are infrequent somatic targets in melanoma. (2006) (71)
The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. (2009) (69)
SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. (2013) (67)
Fluorescence In Situ Hybridization as an Ancillary Tool in the Diagnosis of Ambiguous Melanocytic Neoplasms: A Review of 804 Cases (2014) (66)
Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion (2015) (64)
Consumption of the Epidermis: A Diagnostic Criterion for the Differential Diagnosis of Melanoma and Spitz Nevus (2004) (63)
A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT. (2016) (63)
Assessment of Copy Number Status of Chromosomes 6 and 11 by FISH Provides Independent Prognostic Information in Primary Melanoma (2011) (61)
Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42 (2018) (59)
Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid (1996) (59)
GNAQ and GNA11 mutations in melanocytomas of the central nervous system (2012) (58)
Spitz Melanoma is a Distinct Subset of Spitzoid Melanoma (2019) (57)
A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity (2015) (56)
The genomic landscapes of individual melanocytes from human skin (2020) (56)
Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation (2017) (56)
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle (2018) (55)
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity (2016) (52)
Erythropoietin Receptor Contributes to Melanoma Cell Survival in vivo (2011) (51)
Molecular Analysis of a Case of Nevus of Ota Showing Progressive Evolution to Melanoma With Intermediate Stages Resembling Cellular Blue Nevus (2010) (49)
Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer (2019) (49)
The genetic landscape of gliomas arising after therapeutic radiation (2018) (48)
Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects. (1996) (47)
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. (2019) (45)
Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway (2018) (41)
Filigree-like Rete Ridges, Lobulated Nests, Rosette-like Structures, and Exaggerated Maturation Characterize Spitz Tumors With NTRK1 Fusion (2019) (41)
Germline Variation Controls the Architecture of Somatic Alterations in Tumors (2010) (38)
Melanoma from bench to bedside: meeting report from the 6th international melanoma congress (2010) (38)
Molecular cytogenetics as a diagnostic tool for typing melanocytic tumors. (2002) (37)
Annexins in cancer and autoimmune diseases (1997) (36)
Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy. (1999) (35)
Next-Generation Sequencing of Uveal Melanoma for Detection of Genetic Alterations Predicting Metastasis (2019) (34)
Atypical junctional melanocytic proliferations in benign lichenoid keratosis. (2003) (33)
A Mouse Model Uncovers LKB1 as an UVB-Induced DNA Damage Sensor Mediating CDKN1A (p21WAF1/CIP1) Degradation (2014) (31)
Hypothesis: a role for telomere crisis in spontaneous regression of melanoma. (2003) (30)
Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation (2016) (29)
Primary cutaneous natural killer/T-cell lymphoma. (1998) (29)
Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution (2016) (29)
MicroRNA ratios distinguish melanomas from nevi. (2020) (28)
Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features. (2019) (28)
Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma. (2010) (28)
Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations (2019) (28)
MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells (2013) (27)
Genome‐wide associations studies for melanoma and nevi (2009) (27)
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival (2014) (27)
Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction. (1993) (27)
Regulatory Network Decoded from Epigenomes of Surface Ectoderm-Derived Cell Types (2014) (27)
Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile (2018) (27)
CNVkit: Copy number detection and visualization for targeted sequencing using off-target reads (2014) (26)
The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial (2015) (26)
Localization of annexins in normal and diseased human skin. (1993) (25)
Molecular genetics of melanocytic neoplasia: practical applications for diagnosis. (2004) (24)
Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma. (2011) (24)
Nodular lesions arising in a large congenital melanocytic naevus in a newborn with eruptive disseminated Spitz naevi (2011) (23)
Chromosomal copy number analysis in melanoma diagnostics. (2014) (22)
Eosinophilic globules in spitz nevi: no evidence for apoptosis. (1998) (22)
Functional characterization of uveal melanoma oncogenes (2020) (22)
Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool. (2003) (21)
Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings. (2015) (20)
Adult rhabdomyoma of the lip. (1998) (20)
An unconventional deep penetrating melanocytic nevus with microscopic involvement of regional lymph nodes (2012) (19)
Beyond BRAF in melanoma. (2012) (19)
Inactivating MUTYH germline mutations in pediatric patients with high-grade midline gliomas. (2016) (19)
Constitutive activation of the phosphatidyl inositol 3 kinase signalling pathway in acral lentiginous melanoma (2007) (18)
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. (2016) (18)
Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation (2018) (17)
Molecular-microscopical correlation in dermatopathology. (2011) (16)
Targeting activated KIT signaling for melanoma therapy. (2013) (16)
Signet-ring cell formation in cutaneous neoplasms. (1999) (16)
Allele‐specific imbalance mapping identifies HDAC9 as a candidate gene for cutaneous squamous cell carcinoma (2014) (16)
Cyclin D 1 Is a Candidate Oncogene in Cutaneous Melanoma 1 (2002) (15)
Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes (2020) (15)
Autoantibodies to annexins: a diagnostic marker for cutaneous disorders? (1994) (15)
Elevated Cutaneous Smad Activation Associates with Enhanced Skin Tumor Susceptibility in Organ Transplant Recipients (2009) (14)
The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma (2020) (14)
Absence of PDGFRA mutations in primary melanoma. (2008) (13)
Melanoma pathology: new approaches and classification * (2021) (13)
Genomic approaches to skin cancer diagnosis. (2001) (13)
Primary neuroendocrine carcinoma of the skin with an unusual follicular lymphocytic infiltrate of the dermis. (1996) (13)
FMelanoma from bench to bedside: meeting report from the 6th international melanoma congress. Pigment Cell Melanoma Res. 23, 14-26 (2010) (13)
Genomic analysis of melanocytic neoplasia. (2005) (13)
The longer your telomeres, the larger your nevus? (2003) (12)
An isolated Merkel cell carcinoma metastasis at a distant cutaneous site presenting as a second ‘primary’ tumor (2011) (12)
[Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study]. (1994) (11)
A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation (1998) (11)
Establishment of a novel melanoma cell line SMYM‐PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas (2007) (11)
Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts (2018) (11)
Eruptive Spitz nevus, a striking example of benign metastasis (2020) (9)
Lack of somatic alterations of MC1R in primary melanoma (2008) (9)
[DNA copy number changes in the diagnosis of melanocytic tumors]. (2007) (8)
Progress in the delivery of siRNA therapeutics: Potential in uveal melanoma (2011) (8)
Multiple Merkel cell carcinomas: Late metastasis or multiple primary tumors? A molecular study (2017) (7)
The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma (2018) (7)
[Microcystic adnexal carcinoma of the skin. An underestimated tumor]. (1996) (7)
GNAQ (guanine nucleotide binding protein (G protein), q polypeptide) (2012) (6)
Melanoma BRAF Fusions—Letter (2014) (6)
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. (2021) (5)
PTCH1 Mutation in a Patient With Metastatic Undifferentiated Carcinoma With Clear Cell Change. (2019) (5)
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi. (2021) (5)
Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome (2021) (4)
[Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect]. (1991) (4)
Persistent (Recurrent) Spitz Nevi (2002) (4)
[Pilomatrix carcinoma in an unusual location. Case report and review of the literature]. (1999) (4)
148 Combined activation of MAP kinase and beta-catenin signaling define deep penetrating nevi (2017) (4)
Abstract 3587: XL184: c-Met inhibition is effective in a mouse xenograft model of metastatic uveal melanoma (2011) (4)
Germline variation of the melanocortin‐1 receptor does not explain shared risk for melanoma and thyroid cancer (2009) (4)
Sunitinib therapy for metastatic melanomas with KIT aberrations. (2010) (4)
[Prognostic advantage for defined risk groups by lymphocyte dissection. Long-term study of 3,616 melanoma patients]. (1994) (3)
Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes (2022) (3)
Giant lichenification of the vulva with marked ulcerations. A case report. (1991) (3)
Next-generation sequencing of FFPE solid tumor specimens for clinical use. (2012) (3)
Co-occurring alterations in the RAS-MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation positive lung cancer (2018) (3)
Expanding the genetic spectrum of pigmentation (2008) (3)
Association of Indoor Tanning Exposure with Age at Melanoma Diagnosis and BRAF V600E Mutations. (2019) (3)
Abstract NG07: Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution (2018) (3)
A phase I/II trial of DTIC and dasatinib in metastatic melanoma. (2010) (3)
Abstract LB-125: Germline mutations in BAP1 predispose to melanocytic nevi and melanoma (2011) (3)
Braf and Melanocytic diseases. (2004) (3)
Coalescing, Nevoid Papules in an Infant—Quiz Case (2005) (3)
Ewing sarcoma in a child with neurofibromatosis type 1 (2019) (3)
Identification of FGFR2 as a novel melanoma oncogene (2005) (3)
Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1α and TNF-α (1996) (3)
Raising the bar for melanoma cancer gene discovery (2012) (3)
Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation? (2017) (2)
HDM 2 Protein Overexpression , but not Gene Amplification , is Related to Tumorigenesis of Cutaneous Melanoma 1 (2001) (2)
Next-generation sequencing of genomic and cDNA to identify a high frequency of kinase fusions involving ROS1, ALK, RET, NTRK1, and BRAF in Spitz tumors. (2013) (2)
Genetic polymorphism in Methylenetetrahydrofolate Reductase chloride transport protein 6 (MTHFR CLCN6) gene is associated with keratinocyte skin cancer in a cohort of renal transplant recipients (2022) (2)
Co-occurring genetic alterations in the RAS pathway promote resistance to MET inhibitor treatment in non-small cell lung cancer with a MET exon 14 skipping mutation (2018) (2)
The Genetic Evolution of Melanoma. (2016) (2)
Abstract 2372: The genetic evolution of melanoma (2016) (2)
Coalescing, nevoid papules in an infant. (2005) (2)
Author Correction: From melanocytes to melanomas (2020) (2)
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement. (2023) (2)
Concurrent driver mutations in non-small cell lung cancer (NSCLC) patients (p) on targeted therapy uncovered by comprehensive molecular profiling. (2013) (2)
Improved prognosis for defined risk groups by lymph node dissection. Long-term study of 3616 melanoma patients (1994) (2)
Abstract 3671: A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression (2012) (2)
769P APOBEC signatures and high tumour mutational burden as predictors of clinical outcomes and response to therapy in patients with urothelial carcinoma (2020) (1)
Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes (2022) (1)
Visualizing somatic alterations in spatial transcriptomics data of skin cancer (2022) (1)
Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts (2018) (1)
CNVkit: copy number variant detection and visualization from targeted DNA resequencing (2014) (1)
Comment on "Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT". (2010) (1)
Genetc and morphologic features for melanoma classification: implications for clinical trials (2010) (1)
Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1 alpha and TNF-alpha. (1996) (1)
RESPONSE: Re: Determinants of BRAF Mutations in Primary Melanomas (2005) (1)
Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting. (2020) (1)
Abstract 2968: Exome sequencing of desmoplastic melanoma reveals recurrent NFKBIE promoter mutations and diverse MAPK/PI3K pathway activating mutations (2015) (1)
Correlation of tumor mutational burden (TMB) with molecular profiling and clinical characteristics in patients with bladder cancer. (2020) (1)
Filling the gaps in the genomic catalogue of melanoma subtypes (2017) (1)
Supporting Methods (2003) (1)
Related to Tumorigenesis of Cutaneous Melanoma HDM 2 Protein Overexpression , but not Gene Amplification , is Updated (2001) (1)
Abstract 2138: RasGRP3 mediates MAPK pathway activation in GNAQ mutant uveal melanoma (2015) (1)
Developmental biology of melanocytes (2018) (1)
Iris and ciliary body melanocytomas are defined by solitary GNAQ mutation without additional oncogenic alterations. (2022) (1)
A machine-learning classifier trained with microRNA ratios to distinguish melanomas from nevi (2018) (1)
GNA11 (guanine nucleotide binding protein (G protein), alpha 11 (Gq class)) (2012) (1)
Interactive system for registering adjacent tissue sections (1998) (1)
[Computer networks in clinical practice--a histology data bank system]. (1991) (0)
Somatic Genetic Alterations in Melanoma: Implications for Diagnosis, Classification, and Therapy Stratification (2012) (0)
Faculty Opinions recommendation of ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. (2008) (0)
Title The genetic landscape of ganglioglioma Permalink (2018) (0)
Insights into melanocytic neoplasia from molecular cytometry: 3 (1997) (0)
Methods and combinations of probes for detecting melanoma (2006) (0)
The genetic evolution of melanoma: 48 case studies (2017) (0)
Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma (2019) (0)
1112PPHASE II STUDY OF NILOTINIB IN MELANOMA HARBORING KIT ALTERATIONS FOLLOWING PROGRESSION OR INTOLERANCE TO PRIOR KIT INHIBITION. (2014) (0)
Pervasive chromosomal instability and karyotype order in tumour evolution (2020) (0)
Abstract 1743: SOX10 is required for cell cycle regulation and melanomagenesis. (2013) (0)
Author Correction: From melanocytes to melanomas (2020) (0)
Phospholipase A2 synthesis in murine keratinocytes is induced by IL-1β and TNF-α: Dexamethasone blocks the induced synthesis (1994) (0)
Distinct Genetic Pathways Leading to Melanoma Depending on Anatomic Site and UV Exposure (0)
LOSS-OF-FUNCTION FGFR2 MUTATIONS IN MELANOMA (2017) (0)
[Benign giant cell tumor of the tendon sheath. A differential diagnosis of cutaneous tumors near the joint]. (1994) (0)
LOSS-OF-FUNCTION FGFR 2 MUTATIONS IN MELANOMA (2012) (0)
The genetic landscape of ganglioglioma (2018) (0)
Faculty Opinions recommendation of Central role of p53 in the suntan response and pathologic hyperpigmentation. (2007) (0)
Faculty Opinions recommendation of A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. (2008) (0)
Publisher Correction: The genomic landscapes of individual melanocytes from human skin (2021) (0)
Targeted next-generation DNA sequencing of paired tumor and normal DNA to reveal frequent actionable germline alterations. (2017) (0)
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets (2019) (0)
786 A machine-learning classifier trained with microRNA ratios to distinguish melanomas from nevi (2019) (0)
Oncogene mutations of C-kit in melanomas (2006) (0)
Signet-ring cell differentiation in primary cutaneous neoplasms: 35 (1997) (0)
Atlas of Genetics and Cytogenetics in Oncology and Haematology Skin : Spitz tumors (2013) (0)
Abstract 1812: Adaptive and acquired resistance to GNAQ/11 inhibition in uveal melanoma (2020) (0)
Genomic and Transcriptom ic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution Graphical (2018) (0)
Abstract 2345: Combined inhibition of protein kinase C and MEK is a rational therapeutic approach for melanomas with GNAQ or GNA11 mutations. (2013) (0)
TB-02UPFRONT, REAL-TIME TUMOR AND GERMLINE SEQUENCING OF PEDIATRIC BRAIN TUMOR PATIENTS: THE UCSF EXPERIENCE. (2016) (0)
Genetic alterations in uveal melanoma (2011) (0)
Tracing cancer evolution and heterogeneity using Hi-C (2023) (0)
Spitz Tumors (2019) (0)
Abstract 5518: Bi-allelic loss of CDKN2A initiates melanoma invasion and metastasis via E2F1-BRN2 axis (2018) (0)
Abstract 3885: A secondary Gαq mutation confers resistance to Gαq inhibitors in uveal melanoma (2023) (0)
Publisher Correction: The genomic landscapes of individual melanocytes from human skin (2021) (0)
Abstract 4857: Allelic-specific imbalance mapping identifiesHDAC9as a candidate susceptibility gene for cutaneous squamous cell carcinoma (2012) (0)
Textbook of Melanoma (2004) (0)
Molecular Pathology of Cutaneous Melanoma and Nonmelanoma Skin Cancer (2013) (0)
Identification of markers RREB1, MYB, CCND1 and centromere 6 for the discrimination between melanoma and nevi FFPE skin biopsies using fish (2007) (0)
Spectrum of Melanocytic Tumors Harboring BRAF Gene Fusions: 58 Cases with Histomorphologic and Genetic Correlations. (2023) (0)
The Genomic Landscape of Ganglioglioma (2018) (0)
Absence of HTLV-Related Sequences in Skin Lesions and Peripheral Blood of Cutaneous T-Cell Lymphomas (2009) (0)
Abstract 965: Massively parallel sequencing of cancer FFPE specimens matches diagnostic accuracy of methods in current clinical use and reveals additional actionable mutations (2012) (0)
Absence of somatic mutations of NEMO in keratoacanthoma. (2009) (0)
Melanoma from bench to bedside: Meeting report from the 6th international melanoma congress (Pigment Cell and Melanoma Research (2010) 23, (14-26 )) (2010) (0)
[Giant cell fibroblastoma. A rare soft tissue tumor in childhood]. (1996) (0)
Functional characterization of FGFR2 mutations in melanoma reveals multiple mechanisms of inactivation (2006) (0)
Genetic Progression From Melanocyte to Malignant Melanoma (2006) (0)
Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi (2017) (0)
Phenotype-genotype correlation of malignant melanoma (2006) (0)
1220 MicroRNA signature distinguishing nevi from primary melanoma (2018) (0)
Distribution and Significance of Occult Intraepidermal Tumor Cells Surrounding Primary (2008) (0)
Faculty Opinions recommendation of SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. (2006) (0)
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle (2018) (0)
The genomic landscapes of individual melanocytes from human skin (2020) (0)
Title: Co-occurring alterations in the RAS-MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation positive lung cancer (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Boris C. Bastian?

Boris C. Bastian is affiliated with the following schools:

Boris C. Bastian's Academic­Influence.com Rankings

Boris C. Bastian's Degrees

Similar Degrees You Can Earn

Why Is Boris C. Bastian Influential?

Boris C. Bastian's Published Works

Published Works

What Schools Are Affiliated With Boris C. Bastian?

Boris C. Bastian's AcademicInfluence.com Rankings